Janku Filip 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Janku Filip（CIK 1862930）在 1 家公司共报告 11 笔 SEC Form 4 内部人交易（最近一笔 2026-07-01）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-07-01 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Medical Officer | 买入 | 5,407 | $72,508 |
| 2026-07-01 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Medical Officer | 卖出 | 5,407 | $132,472 |
| 2026-06-30 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Medical Officer | 买入 | 6,000 | $45,360 |
| 2026-06-30 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Medical Officer | 卖出 | 6,000 | $137,700 |
| 2026-06-25 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Medical Officer | 买入 | 6,000 | $45,360 |
| 2026-06-25 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Medical Officer | 卖出 | 11,845 | $239,506 |
| 2026-06-25 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Medical Officer | 买入 | 30,000 | $226,800 |
| 2026-06-25 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Medical Officer | 卖出 | 30,000 | $642,600 |
| 2026-02-24 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Medical Officer | 卖出 | 9,189 | $179,186 |
| 2026-01-05 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Medical Officer | 买入 | 31,000 | $0 |
| 2026-01-05 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Medical Officer | 卖出 | 3,155 | $47,861 |
来源：SEC Form 4 申报文件 · 截至 2026-07-01